Skip to content

Role of Triphaladi mouthwash in patients of dental caries.

Clinical evaluation of an Ayurvedic formulation- Triphaladi Gandusha for its Krimidanta Pratishedha (anti-caries) activity in High Risk Dental Caries patients. - -

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012165
Enrollment
40
Registered
2018-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- dental caries with blackish discolouration and cavity formation

Interventions

Intervention1: Triphaladi Mouthwash : 1. Drug preparation It was prepared by two methods Method-1 An aqueous solution was prepared on the basis of method described in the study done at Rajah Muthiah D

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: High risk patients of dental caries (Hereditary susceptible along with patients having more than 3 DMF index and the patients in the age group 5 to 40 years of lowered pH & buffering capacity along with microbial load in salivary samples) were included in this study.

Exclusion criteria

Exclusion criteria: Patients of chronic debilitating diseases, diabetes mellitus, endocrine dysfunction, pregnant women, age group below 5 & above 40 etc. were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Triphaladi Gandusha Retention was provided better results in Ruja Dantaharsha Sarambha pH microbial count. And Triphaladi Gandusha Mouthrinse was provided better results in Srava Bad Breath pH and Buffering capacity.Timepoint: Result was assesses after completion of one month treatment.

Secondary

MeasureTime frame
rather than justTimepoint: upto present study

Countries

India

Contacts

Public ContactAchyuta

Ph.D. (Ayu)

bhatrajma2008@gmail.com7600901848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026